• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类肺癌的抗原异质性。

Antigenic heterogeneity of human lung cancers.

作者信息

Harłozińska A, Richter R, Albert Z, Zawadzka H

出版信息

J Natl Cancer Inst. 1983 Mar;70(3):427-33.

PMID:6300497
Abstract

Antigenic reactivity of 35 perchloric acid (PCA) extracts of different histologic human lung cancer tissues was studied--in comparison with the reactivity of the carcinoembryonic antigen (CEA), the nonspecific cross-reacting antigen (NCA), and alpha-1-antichymotrypsin--with the use of specific immune sera against PCA extracts of lung squamous cell carcinoma, and anti-CEA, anti-NCA, and anti-alpha-1-antichymotrypsin sera. The following antigenic systems were found in lung cancers: a) antigens specific for most squamous cell cancers and adenocarcinomas, which are undetectable in small cell cancers; b) NCA-type antigens; c) CEA-like antigens; and d) the antigen responsible for alpha-1-antichymotrypsin reactivity. A considerable antigenic heterogeneity among lung cancers indicates the necessity for precise histopathologic verification of individual lung cancer cases before commencement of immunologic studies and purification of antigens specific for lung cancers.

摘要

研究了35种不同组织学类型的人肺癌组织的高氯酸(PCA)提取物的抗原反应性,并与癌胚抗原(CEA)、非特异性交叉反应抗原(NCA)和α-1抗糜蛋白酶的反应性进行比较,使用针对肺鳞状细胞癌PCA提取物的特异性免疫血清以及抗CEA、抗NCA和抗α-1抗糜蛋白酶血清。在肺癌中发现了以下抗原系统:a)大多数鳞状细胞癌和腺癌特有的抗原,在小细胞癌中未检测到;b)NCA型抗原;c)CEA样抗原;d)负责α-1抗糜蛋白酶反应性的抗原。肺癌之间存在相当大的抗原异质性,这表明在开始免疫研究和纯化肺癌特异性抗原之前,有必要对个体肺癌病例进行精确的组织病理学验证。

相似文献

1
Antigenic heterogeneity of human lung cancers.人类肺癌的抗原异质性。
J Natl Cancer Inst. 1983 Mar;70(3):427-33.
2
Immunological reactivity of glycoprotein antigens from human lung cancers.人肺癌糖蛋白抗原的免疫反应性。
Neoplasma. 1980;27(6):641-52.
3
CEA-like antigens in different histologic types of human lung carcinoma.人肺癌不同组织学类型中的癌胚抗原样抗原。
Neoplasma. 1979;26(2):145-56.
4
Tumor-associated antigens in female genital tract cancers.
Tumori. 1984 Jun 30;70(3):281-9. doi: 10.1177/030089168407000315.
5
Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas.抗癌胚抗原和抗肿瘤相关糖蛋白72单克隆抗体在肺癌中的互补反应性。
Cancer Res. 1990 Nov 1;50(21):6987-94.
6
Study of substances related to carcinoembryonic antigens, CEA-NCA and association with alpha1-antichymotrypsin.癌胚抗原相关物质、癌胚抗原-非癌胚抗原及与α1-抗糜蛋白酶关联的研究
Acta Pathol Microbiol Scand C. 1976 Jun;84(3):235-44.
7
Immunological reactivity of mucinous and serous ovarian adenocarcinomas.黏液性和浆液性卵巢腺癌的免疫反应性。
Cancer Detect Prev. 1986;9(3-4):347-58.
8
[Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen].血清糖类抗原19-9在肺癌中的临床评估——与癌胚抗原的比较
Gan To Kagaku Ryoho. 1987 Mar;14(3 Pt 1):711-5.
9
[Diagnostic value of the assay of carbohydrate antigen 19-9 in patients with primary bronchial cancer].
Rev Pneumol Clin. 1985;41(5):314-6.
10
Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.非特异性交叉反应抗原50/90在乳腺癌、肺癌和结肠癌患者中升高。
Cancer Res. 1994 Mar 1;54(5):1227-34.

引用本文的文献

1
Characterization of prostate-tissue-directed monoclonal antibody, alpha-Pro 13.前列腺组织定向单克隆抗体α-Pro 13的特性分析
Cancer Immunol Immunother. 1984;17(1):7-17. doi: 10.1007/BF00205491.
2
Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series.髓细胞系各成熟阶段的非特异性交叉反应抗原(NCA)
Br J Cancer. 1985 Mar;51(3):371-7. doi: 10.1038/bjc.1985.49.
3
A monoclonal antibody (Po66) directed against human lung squamous cell carcinoma immunolocalization of tumour xenografts in nude mice.
一种针对人肺鳞状细胞癌的单克隆抗体(Po66)对裸鼠体内肿瘤异种移植物的免疫定位。
Cancer Immunol Immunother. 1987;24(3):263-8. doi: 10.1007/BF00205641.